[{"AccountsPayableCurrent_0_Q2_USD":9216000.0,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":8786000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8999000.0,"PreferredStockValue_0_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":245000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":223268000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":18054000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":1600000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":62711000.0,"OtherNoncashIncomeExpense_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":77000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":16000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-242000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":244971000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-50000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":16000.0,"OtherAssetsNoncurrent_0_Q2_USD":4140000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":312000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1524000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1559000.0,"OperatingIncomeLoss_2_Q2_USD":51581000.0,"OperatingIncomeLoss_1_Q2_USD":31943000.0,"NonoperatingIncomeExpense_2_Q2_USD":385000.0,"NonoperatingIncomeExpense_1_Q2_USD":110000.0,"NetIncomeLoss_2_Q2_USD":49988000.0,"NetIncomeLoss_1_Q2_USD":26523000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":42000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":69761000.0,"ProfitLoss_2_Q2_USD":49988000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1414000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":128204000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":126680000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":6700000.0,"UnrecognizedTaxBenefitsPeriodIncreaseDecrease_2_Q2_USD":800000.0,"UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1_Q2_USD":600000.0,"TreasuryStockValueAcquiredCostMethod_1_Q2_USD":29170000.0,"TreasuryStockShares_0_Q2_shares":9500000.0,"TreasuryStockCommonValue_0_Q2_USD":164263000.0,"TaxesPayableCurrent_0_Q2_USD":665000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":6661000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":2700000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q2_shares":900000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":3781000.0,"StockholdersEquity_0_Q2_USD":522675000.0,"SharesPaidForTaxWithholdingForShareBasedCompensation_1_Q2_shares":100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":26000000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_2_Q2_USD":21273000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q2_USD":11131000.0,"ShareBasedCompensation_2_Q2_USD":21169000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":59538000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":30029000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":171025000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":91588000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":132444000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":57254000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":28232000.0,"SharesPaidForTaxWithholdingForShareBasedCompensation_2_Q2_shares":1000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":21458000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-71979000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":-34000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-2061000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":33741000.0,"CostsAndExpenses_2_Q2_USD":119444000.0,"CostsAndExpenses_1_Q2_USD":59645000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":2652000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":1384000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":49788000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":26489000.0,"CommonStockValue_0_Q2_USD":125000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":19240000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":95430000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":514000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":95430000.0,"AssetsCurrent_0_Q2_USD":411270000.0,"Assets_0_Q2_USD":568480000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11131000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":3238000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":554154000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":215000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2367000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":760000.0,"AccruedMarketingCostsCurrent_0_Q2_USD":729000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":21514000.0,"AccruedIncomeTaxesNoncurrent_0_Q2_USD":403000.0,"AccountsReceivableNetCurrent_0_Q2_USD":27620000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":445512000.0,"EarningsPerShareBasic_1_Q2_USD":0.23,"EarningsPerShareBasic_2_Q2_USD":0.43,"EarningsPerShareDiluted_1_Q2_USD":0.21,"MarketableSecuritiesNoncurrent_0_Q2_USD":101657000.0,"MarketableSecuritiesCurrent_0_Q2_USD":274552000.0,"LossContingencyAccrualProvision_2_Q2_USD":0.0,"LossContingencyAccrualAtCarryingValue_0_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":45402000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":568480000.0,"Liabilities_0_Q2_USD":45805000.0,"InventoryNoncurrent_0_Q2_USD":14734000.0,"InventoryNet_0_Q2_USD":4669000.0,"InterestReceivableCurrent_0_Q2_USD":1400000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":11649000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":10386000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2047000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-860000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":333000.0,"IncreaseDecreaseInOperatingLeaseLiability_2_Q2_USD":-992000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-1858000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1422000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1304000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":1978000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":5530000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":51966000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":32053000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_2_Q2_USD":104000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q2_USD":63000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7740000.0,"EarningsPerShareDiluted_2_Q2_USD":0.39,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":116294000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":116555000.0,"Ticker":"CORT","CIK":"1088856","name":"CORCEPT THERAPEUTICS INC","OfficialName":"Corcept Therapeutics Incorporated Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2458327425.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210729"}]